JO3172B1 - تركيبة وطريقة وتحضير الصفراء الصناعية - Google Patents

تركيبة وطريقة وتحضير الصفراء الصناعية

Info

Publication number
JO3172B1
JO3172B1 JOP/2008/0286A JOP20080286A JO3172B1 JO 3172 B1 JO3172 B1 JO 3172B1 JO P20080286 A JOP20080286 A JO P20080286A JO 3172 B1 JO3172 B1 JO 3172B1
Authority
JO
Jordan
Prior art keywords
preparation
acid composition
bile acid
synthetic bile
free
Prior art date
Application number
JOP/2008/0286A
Other languages
English (en)
Inventor
Rathan Prasad Achampeta
Kumar Sahoo Akhila
Gregory Reid John
M Moriarty Robert
A Swaringen Roy Jr
E David Nathaniel
Ahmeduddin Mahmood Nadir
Original Assignee
Kythera Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41226994&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JO3172(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US12/035,339 external-priority patent/US20080318870A1/en
Priority claimed from GB0807615A external-priority patent/GB2452358C/en
Application filed by Kythera Biopharmaceuticals Inc filed Critical Kythera Biopharmaceuticals Inc
Application granted granted Critical
Publication of JO3172B1 publication Critical patent/JO3172B1/ar

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)

Abstract

يتعلق الاختراع الحالي بأحماض صفراوية وتركيبات وطرق لتخليقها واستخدامها. وعلى نحو أكثر تحديداً، يتعلق الاختراع بحمض ديوكسي كوليك والتركيبات ذات الصلة، حيث تكون التركيبات المذكورة خالية من جميع الشقوق ذات الأصل الحيواني وخالية من شقوق مولدة للسخونة.
JOP/2008/0286A 2007-06-19 2008-06-18 تركيبة وطريقة وتحضير الصفراء الصناعية JO3172B1 (ar)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US94503507P 2007-06-19 2007-06-19
US95687507P 2007-08-20 2007-08-20
US12/035,339 US20080318870A1 (en) 2007-06-19 2008-02-21 Synthetic bile acid compositions and methods
GB0807615A GB2452358C (en) 2008-04-25 2008-04-25 Preparation of bile acids.
US12/153,446 US7902387B2 (en) 2008-04-25 2008-05-16 Preparation of bile acids and intermediates thereof

Publications (1)

Publication Number Publication Date
JO3172B1 true JO3172B1 (ar) 2018-03-08

Family

ID=41226994

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2008/0286A JO3172B1 (ar) 2007-06-19 2008-06-18 تركيبة وطريقة وتحضير الصفراء الصناعية

Country Status (28)

Country Link
EP (3) EP3002290B1 (ar)
JP (2) JP2010530876A (ar)
KR (7) KR20100031512A (ar)
CN (4) CN106083969B (ar)
AR (1) AR067440A1 (ar)
AU (1) AU2008265721B2 (ar)
BR (1) BRPI0813140C1 (ar)
CA (2) CA2789109C (ar)
CR (2) CR20170070A (ar)
CY (1) CY1116700T1 (ar)
DK (1) DK2407475T3 (ar)
EA (1) EA020806B1 (ar)
ES (2) ES2550504T3 (ar)
HR (1) HRP20150879T1 (ar)
HU (1) HUE025909T2 (ar)
IL (1) IL202203B (ar)
JO (1) JO3172B1 (ar)
MX (2) MX360094B (ar)
MY (1) MY160040A (ar)
NZ (1) NZ581081A (ar)
PH (1) PH12013500364A1 (ar)
PL (1) PL2407475T3 (ar)
PT (1) PT2407475E (ar)
SI (1) SI2407475T1 (ar)
SM (1) SMP201000003B (ar)
TW (2) TWI503327B (ar)
WO (1) WO2008157635A2 (ar)
ZA (1) ZA200907928B (ar)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3172B1 (ar) * 2007-06-19 2018-03-08 Kythera Biopharmaceuticals Inc تركيبة وطريقة وتحضير الصفراء الصناعية
US8242294B2 (en) 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
JOP20180077A1 (ar) 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc تركيبات وطرق لحمض صفراوي تخليقي
US20080318870A1 (en) 2007-06-19 2008-12-25 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
GB2480632A (en) * 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
BR112013003216A2 (pt) * 2010-08-12 2016-05-17 Kythera Biopharmaceuticals Inc composições sintéticas de ácido biliar e métodos
EP3138850B8 (en) * 2011-06-16 2019-09-11 Allergan Sales, LLC Compositions containing deoxycholic acid and 10% deionized water in ethanol, directed to the purification of deoxycholic acid
US20130102580A1 (en) * 2011-09-22 2013-04-25 Kythera Biopharmaceuticals, Inc. Compositions and methods related to deoxycholic acid and its polymorphs
WO2013142873A2 (en) * 2012-03-23 2013-09-26 The Board Of Trustees Of The University Of Illinois Complex and structurally diverse compounds
CN103059087B (zh) * 2012-12-30 2015-10-14 中山百灵生物技术有限公司 一种脱氧胆酸的合成方法
KR101447901B1 (ko) * 2013-04-16 2014-10-16 한양대학교 산학협력단 지방세포 표적 비바이러스성 유전자 전달체
US10414791B2 (en) * 2015-07-30 2019-09-17 Intercept Pharmaceuticals, Inc Methods for preparation of bile acids and derivatives thereof
MX2018005628A (es) * 2015-11-04 2018-08-01 Kythera Biopharmaceuticals Inc Tratamientos de grasa acumulada con acido desoxicolico y sales del mismo.
KR102527103B1 (ko) * 2016-06-06 2023-04-28 크리스탈 파마 에스.에이.유. 디옥시콜린산 제조방법 및 디옥시콜린산의 제조에 유용한 중간물
US11161872B2 (en) 2017-08-03 2021-11-02 Medytox Inc. Methods for preparing bile acids
EP3700916B1 (en) * 2017-10-24 2026-03-18 Curia Spain S.A.U. Preparation of deoxycholic acid
RU2705314C1 (ru) * 2019-03-18 2019-11-06 Федеральное бюджетное учреждение науки "Государственный научный центр прикладной микробиологии и биотехнологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ПМБ) Способ производства сухих очищенных солей желчных кислот для бактериологии
KR102456989B1 (ko) * 2020-06-12 2022-10-21 (주)케어젠 항비만 활성을 가지는 디옥시콜산-펩타이드 결합체 및 이의 용도
WO2022059948A1 (ko) * 2020-09-18 2022-03-24 서울대학교 산학협력단 소디움 타우로디옥시콜레이트의 대량 생산 방법
KR20230013003A (ko) 2021-07-16 2023-01-26 주식회사 스카이테라퓨틱스 담즙산 또는 담즙산 염의 분자 회합체 및 이를 포함하는 국소지방제거용 의약 조성물
WO2023287260A1 (ko) 2021-07-16 2023-01-19 주식회사 스카이테라퓨틱스 담즙산 또는 담즙산 염의 분자 회합체 및 이를 포함하는 국소지방제거용 의약 조성물
CN114478676B (zh) * 2022-02-18 2024-05-10 国药集团化学试剂有限公司 一种脱氧胆酸钠的制备方法
CN115974949B (zh) * 2022-10-26 2023-12-22 湖南科瑞生物制药股份有限公司 一种植物源脱氧胆酸中间体的制备方法
CN118344420A (zh) * 2023-01-16 2024-07-16 北京诺博特生物科技有限公司 一种脱氧胆酸的制备方法
WO2025175304A2 (en) 2024-02-16 2025-08-21 Sanofi Pasteur Inc. Process for the preparation of deoxycholic acid

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2321598A (en) * 1940-10-07 1943-06-15 George A Breon & Company Inc Preparation of desoxycholic acid
US2615902A (en) * 1950-10-24 1952-10-28 Merck & Co Inc Chemical compounds and processes for preparing the same
US4113882A (en) * 1974-10-21 1978-09-12 Yamanouchi Pharmaceutical Co., Ltd. Stabilized oral prostaglandin formulation and the process for the preparation thereof
US4866044A (en) * 1985-07-09 1989-09-12 Takeda Chemical Industries, Ltd. Solubilized composition of poorly-soluble pharmaceutical product
AU618350B2 (en) * 1988-04-08 1991-12-19 Aventis Pharma S.A. 9-alpha-hydroxy-17-methylene steroids, process for their preparation and their use in the preparation of corticosteroids
FR2754709B1 (fr) * 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
GB9910934D0 (en) * 1999-05-11 1999-07-14 Res Inst Medicine Chem Chemical compounds
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
ES2372499T3 (es) * 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
CA2610022A1 (en) 2005-06-06 2006-12-14 Georgetown University Compositions and methods for lipo modeling
JO3172B1 (ar) * 2007-06-19 2018-03-08 Kythera Biopharmaceuticals Inc تركيبة وطريقة وتحضير الصفراء الصناعية

Also Published As

Publication number Publication date
SI2407475T1 (sl) 2016-03-31
ES2826429T3 (es) 2021-05-18
CY1116700T1 (el) 2017-03-15
KR20100031512A (ko) 2010-03-22
BRPI0813140C1 (pt) 2021-05-25
CN106083969A (zh) 2016-11-09
EP2407475A3 (en) 2012-06-13
MY160040A (en) 2017-02-15
KR20130133881A (ko) 2013-12-09
KR20150013305A (ko) 2015-02-04
CA2690841A1 (en) 2008-12-24
BRPI0813140B1 (pt) 2019-02-05
JP2010530876A (ja) 2010-09-16
HRP20150879T1 (hr) 2015-09-25
KR101863131B1 (ko) 2018-06-01
SMP201000003B (it) 2010-11-12
CN108191940B (zh) 2021-02-09
KR101916024B1 (ko) 2018-11-08
JP2013075918A (ja) 2013-04-25
CN106083969B (zh) 2018-02-27
CA2789109C (en) 2015-10-06
CN101711254A (zh) 2010-05-19
AU2008265721A1 (en) 2008-12-24
AU2008265721B2 (en) 2014-03-20
TW200918550A (en) 2009-05-01
TWI503396B (zh) 2015-10-11
MX2009013664A (es) 2010-04-07
HK1165807A1 (en) 2012-10-12
TWI503327B (zh) 2015-10-11
EP2407475B1 (en) 2015-08-12
DK2407475T3 (en) 2015-10-26
CA2690841C (en) 2012-11-27
EP3002290A2 (en) 2016-04-06
EP3002290A3 (en) 2016-06-29
KR101598402B1 (ko) 2016-03-03
JP5589102B2 (ja) 2014-09-10
EA020806B1 (ru) 2015-01-30
CA2789109A1 (en) 2008-12-24
ZA200907928B (en) 2011-05-28
HUE025909T2 (en) 2016-04-28
ES2550504T3 (es) 2015-11-10
KR20180122483A (ko) 2018-11-12
PL2407475T3 (pl) 2015-12-31
CR11174A (es) 2010-03-23
KR102061001B1 (ko) 2020-01-03
HK1223372A1 (en) 2017-07-28
WO2008157635A3 (en) 2009-06-04
CN108191940A (zh) 2018-06-22
IL202203A0 (en) 2010-06-16
PT2407475E (pt) 2015-11-20
EA201000032A1 (ru) 2010-04-30
EP2069383A2 (en) 2009-06-17
CR20170070A (es) 2017-04-27
KR20180061401A (ko) 2018-06-07
KR20160025044A (ko) 2016-03-07
EP3002290B1 (en) 2020-09-09
NZ581081A (en) 2012-12-21
AR067440A1 (es) 2009-10-14
BRPI0813140A2 (pt) 2014-12-23
TW201534684A (zh) 2015-09-16
EP2407475A2 (en) 2012-01-18
PH12013500364A1 (en) 2014-04-28
SMAP201000003A (it) 2010-03-01
CN106146594A (zh) 2016-11-23
WO2008157635A2 (en) 2008-12-24
MX360094B (es) 2018-10-19
KR20160150646A (ko) 2016-12-30
IL202203B (en) 2018-04-30

Similar Documents

Publication Publication Date Title
JO3172B1 (ar) تركيبة وطريقة وتحضير الصفراء الصناعية
JOP20180077A1 (ar) تركيبات وطرق لحمض صفراوي تخليقي
EA201001639A1 (ru) Композиции и способы их получения и применения
EA201170161A1 (ru) 1,2,5-оксадиазолы в качестве ингибиторов индоламин-2,3-диоксигеназы
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
MY148253A (en) Azaadamantane derivatives and methods of use
MX377553B (es) Composicion farmaceutica estable y metodos de uso de la misma.
EA201171151A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
EA201071320A1 (ru) Активаторы глюкокиназы
EA201500650A1 (ru) Фенилацетат l-орнитина и способы его получения
EA200971140A1 (ru) Триарильные соединения и композиции, их содержащие
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
CY1115673T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν 2-οξο-1-πυρρολιδινο παραγωγα
CO6290655A2 (es) Inhibidors heterociclicos de estearoil-coa-desaturasa
BR112013003216A2 (pt) composições sintéticas de ácido biliar e métodos
EA201000814A1 (ru) 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств
ATE509931T1 (de) Azaadamantanester- und carbamatderivate sowie anwendungsverfahren dafür
UA96994C2 (ru) Производные 7-алкинил-1,8-нафтиридонов, способ их получения и их применения в терапии
BR112014011595A2 (pt) método de cimentação e composição de cimento
DOP2009000262A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas
MX2009010176A (es) Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos.
BR112012008680A2 (pt) composição para cuidado oral, e, método para tratar ou prevenir mau odor oral
CY1113835T1 (el) Δραση των εκχυλισματων του φυτου cissampelos pareira εναντι του δαγκειου πυρετου